1-6 of 6
Yi Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell–like Phenotype via Dysregulation of PITX2

Jia-Xing Zhang, Zhen-Hua Chen, Yi Xu, Jie-Wei Chen, Hui-Wen Weng, Miao Yun, Zou-San Zheng, Cui Chen, Bing-Li Wu, En-Min Li, Jian-Hua Fu, Sheng Ye, Dan Xie
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (17): 4942.
https://doi.org/10.1158/1078-0432.CCR-21-2434
Published: 01 September 2021
View article titled, Correction: Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell–like Phenotype via Dysregulation of PITX2
Open the PDF for Correction: Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell–like Phenotype via Dysregulation of PITX2 in another window
Journal Articles

Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell–like Phenotype via Dysregulation of PITX2

Jia-Xing Zhang, Zhen-Hua Chen, Yi Xu, Jie-Wei Chen, Hui-Wen Weng, Miao Yun, Zou-San Zheng, Cui Chen, Bing-Li Wu, En-Min Li, Jian-Hua Fu, Sheng Ye, Dan Xie
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (1): 298–310.
https://doi.org/10.1158/1078-0432.CCR-16-0414
Published: 02 January 2017
View article titled, Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell–like Phenotype via Dysregulation of PITX2
Open the PDF for Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell–like Phenotype via Dysregulation of PITX2 in another window
Includes: Supplementary data
Journal Articles

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

Geoffrey I. Shapiro, Jordi Rodon, Cynthia Bedell, Eunice L. Kwak, Jose Baselga, Irene Braña, Shuchi S. Pandya, Christian Scheffold, A. Douglas Laird, Linh T. Nguyen, Yi Xu, Coumaran Egile, Gerald Edelman
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (1): 233–245.
https://doi.org/10.1158/1078-0432.CCR-13-1777
Published: 05 January 2014
View article titled, Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
Open the PDF for Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer

Tomasz M. Beer, Guy T. Bernstein, John M. Corman, L. Michael Glode, Simon J. Hall, Wayne L. Poll, Paul F. Schellhammer, Lori A. Jones, Yi Xu, Jelle W. Kylstra, Mark W. Frohlich
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4558–4567.
https://doi.org/10.1158/1078-0432.CCR-10-3223
Published: 05 July 2011
View article titled, Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer
Open the PDF for Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer in another window
Journal Articles

Pharmacologic Basis for the Enhanced Efficacy of Dutasteride against Prostatic Cancers

Yi Xu, Susan L. Dalrymple, Robyn E. Becker, Samuel R. Denmeade, John T. Isaacs
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (13): 4072–4079.
https://doi.org/10.1158/1078-0432.CCR-06-0184
Published: 03 July 2006
View article titled, Pharmacologic Basis for the Enhanced Efficacy of Dutasteride against Prostatic Cancers
Open the PDF for Pharmacologic Basis for the Enhanced Efficacy of Dutasteride against Prostatic Cancers in another window
Journal Articles

Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability

Bibo Yuan, Yi Xu, Ju-Hyung Woo, Yunyue Wang, Young Kyung Bae, Dae-Sung Yoon, Robert P. Wersto, Ellen Tully, Kathleen Wilsbach, Edward Gabrielson
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (2): 405–410.
https://doi.org/10.1158/1078-0432.CCR-05-0903
Published: 20 January 2006
View article titled, Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability
Open the PDF for Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability in another window